Linked e-resources
Details
Table of Contents
Part I. Pathophysiology, Molecular Biology, and Clinical Management of Cardiac Repolarization
1. Physiology and Molecular biology of Cardiac Ion Channels and Ventricular Repolarization
2. Cardiac Repolarization and the Autonomic Nervous System
3. Role of Repolarization Remodeling in Organic Heart Disease
4. Stem Cells in Study and Treatment of Cardiac Repolarization
5. Racial and Gender Differences in Cardiac Repolarization and Arrhythmogenesis
6. ECG-derived Evaluation of Cardiac Repolarization
Part II. Pathophysiology, Molecular Biology, and Clinical Management of Long QT Syndromes
7. Physiology and Molecular Biology of Congenital Long QT Syndrome (LQTS)
8. Pharmacotherapeutics and Clinical Management of Congenital LQTS
9. Drug-induced LQTS
10. Arrhythmogenic Mechanism of TdP in LQTS
11. Pathogenesis of Autoimmune-associated LQTS
12. Role of inflammation and Autoimmune Disease in LQTS
13. Future of Genetic Therapy of Congenital LQTS
Part III. Pathophysiology, Molecular Biology, and Clinical Management of Early Repolarization Syndromes
14. Genetics, Molecular biology, and Emerging Concepts of Early Repolarization Syndrome (ERS)
15. Electrocardiographic J-wave and Cardiovascular Risk in the General Population
16. Benign Versus Malignant Early Repolarization Patterns
17. Genetics, Molecular Biology, and Management of Brugada Syndrome
Part IV. Pathophysiology and Clinical Management of Special Cardiac Repolarization Syndromes
18. Genetics, Molecular Biology, and Management of Short QT Syndrome
19. Pathophysiology of Repolarization Alternans
20. Microvolt T-wave Alternans: Pathophysiology and Clinical Aspects
21. Atrial Repolarization and Arrhythmogenesis: Basic and Clinical Aspects.
1. Physiology and Molecular biology of Cardiac Ion Channels and Ventricular Repolarization
2. Cardiac Repolarization and the Autonomic Nervous System
3. Role of Repolarization Remodeling in Organic Heart Disease
4. Stem Cells in Study and Treatment of Cardiac Repolarization
5. Racial and Gender Differences in Cardiac Repolarization and Arrhythmogenesis
6. ECG-derived Evaluation of Cardiac Repolarization
Part II. Pathophysiology, Molecular Biology, and Clinical Management of Long QT Syndromes
7. Physiology and Molecular Biology of Congenital Long QT Syndrome (LQTS)
8. Pharmacotherapeutics and Clinical Management of Congenital LQTS
9. Drug-induced LQTS
10. Arrhythmogenic Mechanism of TdP in LQTS
11. Pathogenesis of Autoimmune-associated LQTS
12. Role of inflammation and Autoimmune Disease in LQTS
13. Future of Genetic Therapy of Congenital LQTS
Part III. Pathophysiology, Molecular Biology, and Clinical Management of Early Repolarization Syndromes
14. Genetics, Molecular biology, and Emerging Concepts of Early Repolarization Syndrome (ERS)
15. Electrocardiographic J-wave and Cardiovascular Risk in the General Population
16. Benign Versus Malignant Early Repolarization Patterns
17. Genetics, Molecular Biology, and Management of Brugada Syndrome
Part IV. Pathophysiology and Clinical Management of Special Cardiac Repolarization Syndromes
18. Genetics, Molecular Biology, and Management of Short QT Syndrome
19. Pathophysiology of Repolarization Alternans
20. Microvolt T-wave Alternans: Pathophysiology and Clinical Aspects
21. Atrial Repolarization and Arrhythmogenesis: Basic and Clinical Aspects.